SARS-CoV-2中和抗体药物的研究进展

{"title":"SARS-CoV-2中和抗体药物的研究进展","authors":"R. Shi, Jingchao Yan","doi":"10.13523/J.CB.2106007","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9919,"journal":{"name":"中国生物工程杂志","volume":"10 1","pages":"129-135"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research Progress of Neutralizing Antibody Drugs against SARS-CoV-2\",\"authors\":\"R. Shi, Jingchao Yan\",\"doi\":\"10.13523/J.CB.2106007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9919,\"journal\":{\"name\":\"中国生物工程杂志\",\"volume\":\"10 1\",\"pages\":\"129-135\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国生物工程杂志\",\"FirstCategoryId\":\"1089\",\"ListUrlMain\":\"https://doi.org/10.13523/J.CB.2106007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国生物工程杂志","FirstCategoryId":"1089","ListUrlMain":"https://doi.org/10.13523/J.CB.2106007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}